Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
American Journal of Hematology|August 9, 2021
Improved survival for young acute leukemia patients following a new donor hierarchy for allogeneic hematopoietic stem cell transplantation: A phase III randomized controlled studyMingming Zhang, Haowen Xiao, Jimin Shi, et al.
International Journal of Hematology|June 2, 2009
Invasive pulmonary fungal infection accompanied by severe hemoptysis in patients with hematologic diseases: a report of nine casesLei Qiu, Jingsong He, Xiujin Ye, et al.
Transplant Immunology|April 5, 2022
Chronic graft-versus-host disease-related polymyositis and myocarditis: A case report and review of the literatureMengni Yan, Fengqin Su, Fei Cheng, et al.
Japanese Journal of Clinical Oncology|May 28, 2020
Obesity is correlated with poor outcome after allogeneic hematopoietic stem cell transplantation in patients with acute leukemiaJian Yu, Shangnao Lin, Yi Luo, et al.
Annals of Hematology|September 5, 2020
Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemiaJian Yu, Xinyi Ge, Yi Luo, et al.
BMC Cancer|January 11, 2017
Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myelomaXiaoyan Han, Lijuan Wang, Hongfei Shi, et al.
Plos One|October 4, 2016
Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaMingming Zhang, Huarui Fu, Xiaoyu Lai, et al.
The American Journal of the Medical Sciences|August 10, 2013
Clinical characteristics and prognosis of nonleukemic myeloid sarcomaJingsong He, Lixia Zhu, Xiujin Ye, et al.
Zhonghua Nei Ke Za Zhi|April 25, 2015
[A clinical observation of treatment of peripheral T-cell lymphoma with L-asparaginase-containing combination chemotherapy]Guoli Yao, Wanzhuo Xie, De Zhou, et al.
Frontiers in Oncology|July 1, 2021
Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Date in ChinaXiaoyan Han, Chunxiang Jin, Gaofeng Zheng, et al.
Pageof 8